Meiji Holdings Co., Ltd. Meiji Holdings Co., Ltd. Financial Results for the First Half of FYE March 2019  


Pharma: KM Biologics, need to recover credibility

Prev. Page Next Page Download the PDF
Restore reliability - Governance and Compliance
Ensure the transparency in business operations

 • Improve organizational structure and reporting structure based on Meiji Group’s governance system

 • Enhance corporate culture through training

Ensure stable supply and improve quality assurance system

 • Technicians/specialists from Meiji Group will work together with KM Biologics

 • Promote appropriate disclosure to employees and the public

These efforts will be checked by president and restore reliability.
No easy way to win back reliability, every one of the employee should work hard

Though the business condition is unclear in both food and pharmaceutical business, we will grow the Meiji Group to achieve 2020 Medium-Term Business Plan.